Intuitive Surgical, Inc. Net Income (Loss) Attributable to Noncontrolling Interest
Intuitive Surgical, Inc. (ISRG) reported Net Income (Loss) Attributable to Noncontrolling Interest of $5.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-21.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-07-21
- Intuitive Surgical, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was $5.10M, a 12.07% decline year-over-year.
- Intuitive Surgical, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was $4.50M, a 15.09% decline year-over-year.
- Intuitive Surgical, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was $4.70M, a 104.35% increase year-over-year.
- Intuitive Surgical, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was $4.80M, a 12.73% decline year-over-year.
- Intuitive Surgical, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2025 was $20.60M, a 38.26% increase from fiscal 2024.
- Intuitive Surgical, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2024 was $14.90M, a 22.80% decline from fiscal 2023.
- Intuitive Surgical, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2023 was $19.30M, a 12.67% decline from fiscal 2022.
- Intuitive Surgical, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2022 was $22.10M, a 5.96% decline from fiscal 2021.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $5.10M 10-Q · filed 2026-07-21 | $9.60M 10-Q · filed 2026-07-21 | $14.30M derived: sum of 3 quarters · filed 2026-07-21 | $19.10M derived: sum of 4 quarters · filed 2026-07-21 | |
| 2026-03-31 | $4.50M 10-Q · filed 2026-04-22 | $9.20M derived: sum of 2 quarters · filed 2026-04-22 | $14.00M derived: sum of 3 quarters · filed 2026-04-22 | $19.80M derived: sum of 4 quarters · filed 2026-07-21 | |
| 2025-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $9.50M derived: sum of 2 quarters · filed 2026-02-03 | $15.30M derived: sum of 3 quarters · filed 2026-07-21 | $20.60M 10-K · filed 2026-02-03 | |
| 2025-09-30 | $4.80M 10-Q · filed 2025-10-22 | $10.60M derived: sum of 2 quarters · filed 2026-07-21 | $15.90M 10-Q · filed 2025-10-22 | $18.20M derived: sum of 4 quarters · filed 2026-07-21 | |
| 2025-06-30 | $5.80M 10-Q · filed 2026-07-21 | $11.10M 10-Q · filed 2026-07-21 | $13.40M derived: sum of 3 quarters · filed 2026-07-21 | $18.90M derived: sum of 4 quarters · filed 2026-07-21 | |
| 2025-03-31 | $5.30M 10-Q · filed 2026-04-22 | $7.60M derived: sum of 2 quarters · filed 2026-04-22 | $13.10M derived: sum of 3 quarters · filed 2026-04-22 | $17.70M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2024-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $7.80M derived: sum of 2 quarters · filed 2026-02-03 | $12.40M derived: sum of 3 quarters · filed 2026-02-03 | $14.90M 10-K · filed 2026-02-03 | |
| 2024-09-30 | $5.50M 10-Q · filed 2025-10-22 | $10.10M derived: sum of 2 quarters · filed 2025-10-22 | $12.60M 10-Q · filed 2025-10-22 | $17.10M derived: sum of 4 quarters · filed 2026-02-03 | |
| 2024-06-30 | $4.60M 10-Q · filed 2025-07-23 | $7.10M 10-Q · filed 2025-07-23 | $11.60M derived: sum of 3 quarters · filed 2026-02-03 | $15.70M derived: sum of 4 quarters · filed 2026-02-03 | |
| 2024-03-31 | $2.50M 10-Q · filed 2025-04-23 | $7.00M derived: sum of 2 quarters · filed 2026-02-03 | $11.10M derived: sum of 3 quarters · filed 2026-02-03 | $16.30M derived: sum of 4 quarters · filed 2026-02-03 | |
| 2023-12-31 | $4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $8.60M derived: sum of 2 quarters · filed 2026-02-03 | $13.80M derived: sum of 3 quarters · filed 2026-02-03 | $19.30M 10-K · filed 2026-02-03 | |
| 2023-09-30 | $4.10M 10-Q · filed 2024-10-18 | $9.30M derived: sum of 2 quarters · filed 2024-10-18 | $14.80M 10-Q · filed 2024-10-18 | $26.60M derived: sum of 4 quarters · filed 2025-01-31 | |
| 2023-06-30 | $5.20M 10-Q · filed 2024-07-19 | $10.70M 10-Q · filed 2024-07-19 | $22.50M derived: sum of 3 quarters · filed 2025-01-31 | $23.20M derived: sum of 4 quarters · filed 2025-01-31 | |
| 2023-03-31 | $5.50M 10-Q · filed 2024-04-19 | $17.30M derived: sum of 2 quarters · filed 2025-01-31 | $18.00M derived: sum of 3 quarters · filed 2025-01-31 | $23.80M derived: sum of 4 quarters · filed 2025-01-31 | |
| 2022-12-31 | $11.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-31 | $12.50M derived: sum of 2 quarters · filed 2025-01-31 | $18.30M derived: sum of 3 quarters · filed 2025-01-31 | $22.10M 10-K · filed 2025-01-31 | |
| 2022-09-30 | $700.00K 10-Q · filed 2023-10-20 | $6.50M derived: sum of 2 quarters · filed 2023-10-20 | $10.30M 10-Q · filed 2023-10-20 | $12.40M derived: sum of 4 quarters · filed 2024-01-31 | |
| 2022-06-30 | $5.80M 10-Q · filed 2023-07-24 | $9.60M 10-Q · filed 2023-07-24 | $11.70M derived: sum of 3 quarters · filed 2024-01-31 | $18.40M derived: sum of 4 quarters · filed 2024-01-31 | |
| 2022-03-31 | $3.80M 10-Q · filed 2023-04-20 | $5.90M derived: sum of 2 quarters · filed 2024-01-31 | $12.60M derived: sum of 3 quarters · filed 2024-01-31 | $18.40M derived: sum of 4 quarters · filed 2024-01-31 | |
| 2021-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-31 | $8.80M derived: sum of 2 quarters · filed 2024-01-31 | $14.60M derived: sum of 3 quarters · filed 2024-01-31 | $23.50M 10-K · filed 2024-01-31 | |
| 2021-09-30 | $6.70M 10-Q · filed 2022-10-21 | $12.50M derived: sum of 2 quarters · filed 2022-10-21 | $21.40M 10-Q · filed 2022-10-21 | $19.80M derived: sum of 4 quarters · filed 2023-02-10 | |
| 2021-06-30 | $5.80M 10-Q · filed 2022-07-22 | $14.70M 10-Q · filed 2022-07-22 | $13.10M derived: sum of 3 quarters · filed 2023-02-10 | $16.00M derived: sum of 4 quarters · filed 2023-02-10 | |
| 2021-03-31 | $8.90M 10-Q · filed 2022-04-22 | $7.30M derived: sum of 2 quarters · filed 2023-02-10 | $10.20M derived: sum of 3 quarters · filed 2023-02-10 | $12.40M derived: sum of 4 quarters · filed 2023-02-10 | |
| 2020-12-31 | -$1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $1.30M derived: sum of 2 quarters · filed 2023-02-10 | $3.50M derived: sum of 3 quarters · filed 2023-02-10 | $6.20M 10-K · filed 2023-02-10 | |
| 2020-09-30 | $2.90M 10-Q · filed 2021-10-20 | $5.10M derived: sum of 2 quarters · filed 2021-10-20 | $7.80M 10-Q · filed 2021-10-20 | $12.80M derived: sum of 4 quarters · filed 2022-02-03 | |
| 2020-06-30 | $2.20M 10-Q · filed 2021-07-21 | $4.90M 10-Q · filed 2021-07-21 | $9.90M derived: sum of 3 quarters · filed 2022-02-03 | $11.80M derived: sum of 4 quarters · filed 2022-02-03 | |
| 2020-03-31 | $2.70M 10-Q · filed 2021-04-21 | $7.70M derived: sum of 2 quarters · filed 2022-02-03 | $9.60M derived: sum of 3 quarters · filed 2022-02-03 | $7.70M derived: sum of 4 quarters · filed 2022-02-03 | |
| 2019-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $6.90M derived: sum of 2 quarters · filed 2022-02-03 | $5.00M derived: sum of 3 quarters · filed 2022-02-03 | $2.50M 10-K · filed 2022-02-03 | |
| 2019-09-30 | $1.90M 10-Q · filed 2020-10-19 | $0.00 derived: sum of 2 quarters · filed 2020-10-19 | -$2.50M 10-Q · filed 2020-10-19 | -$3.70M derived: sum of 4 quarters · filed 2021-02-10 | |
| 2019-06-30 | -$1.90M 10-Q · filed 2020-07-23 | -$4.40M 10-Q · filed 2020-07-23 | -$5.60M derived: sum of 3 quarters · filed 2021-02-10 | -$6.30M derived: sum of 4 quarters · filed 2021-02-10 | |
| 2019-03-31 | -$2.50M 10-Q · filed 2020-04-17 | -$3.70M derived: sum of 2 quarters · filed 2021-02-10 | -$4.40M derived: sum of 3 quarters · filed 2021-02-10 | -$5.10M derived: sum of 4 quarters · filed 2021-02-10 | |
| 2018-12-31 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | -$1.90M derived: sum of 2 quarters · filed 2021-02-10 | -$2.60M derived: sum of 3 quarters · filed 2021-02-10 | -$2.90M 10-K · filed 2021-02-10 | |
| 2018-09-30 | -$700.00K 10-Q · filed 2019-10-18 | -$1.40M derived: sum of 2 quarters · filed 2019-10-18 | -$1.70M 10-Q · filed 2019-10-18 | -$2.10M derived: sum of 4 quarters · filed 2020-02-07 | |
| 2018-06-30 | -$700.00K 10-Q · filed 2019-07-22 | -$1.00M 10-Q · filed 2019-07-22 | -$1.40M derived: sum of 3 quarters · filed 2020-02-07 | -$1.40M derived: sum of 4 quarters · filed 2020-02-07 | |
| 2018-03-31 | -$300.00K 10-Q · filed 2019-04-19 | -$700.00K derived: sum of 2 quarters · filed 2020-02-07 | -$700.00K derived: sum of 3 quarters · filed 2020-02-07 | -$700.00K derived: sum of 4 quarters · filed 2020-02-07 | |
| 2017-12-31 | -$400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | -$400.00K derived: sum of 2 quarters · filed 2020-02-07 | -$400.00K derived: sum of 3 quarters · filed 2020-02-07 | -$400.00K 10-K · filed 2020-02-07 | $400.00K 10-K · filed 2018-02-02 |
| 2017-09-30 | $0.00 10-Q · filed 2018-10-22 | $0.00 derived: sum of 2 quarters · filed 2018-10-22 | $0.00 10-Q · filed 2018-10-22 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-07-20 | $0.00 10-Q · filed 2018-07-20 | |||
| 2017-03-31 | $0.00 10-Q · filed 2018-04-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |